Form 6-K ASTRAZENECA PLC For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
AstraZeneca (AZN) Tops Q3 EPS by 6c
November 10, 2016 8:27 AM ESTAstraZeneca (NYSE: AZN) reported Q3 EPS of $0.80, $0.06 better than the analyst estimate of $0.74. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.95 billion.
Pascal Soriot, Chief Executive Officer, commenting on the results said:
The performance in the third quarter was in line with our expectations,... More



